Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Carruthers

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
BMC Neurology|July 22, 2019
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patientsNick Bansback, Judy A Chiu, Robert Carruthers, et al.
Medicine|June 25, 2013
IgG4-related disease and hypertrophic pachymeningitisZachary S Wallace, Mollie N Carruthers, Arezou Khosroshahi, et al.
NPJ Digital Medicine|November 5, 2022
Representational ethical model calibrationRobert Carruthers, Isabel Straw, James K Ruffle, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 5, 2021
Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosisNick Bansback, Judy A Chiu, Rebecca Metcalfe, et al.
BMJ Open|June 4, 2017
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopeniaKaarina Kowalec, Elaine Kingwell, Robert Carruthers, et al.
Retina (Philadelphia, Pa.)|March 24, 2021
INVESTIGATING MICROANGIOPATHY USING SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH SUSAC SYNDROMEMagdalena A Wirth, Haaris M Khan, Jillian Chan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Effect of different doses of gadolinium contrast agent on clinical outcomes in MSNathalie Ackermans, Carolyn Taylor, Roger Tam, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 9, 2021
Diffusely abnormal white matter in multiple sclerosisJames Cairns, Irene M Vavasour, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2017
Age Related Multiple Sclerosis Severity Score: Disability ranked by ageAli Manouchehrinia, Helga Westerlind, Elaine Kingwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Predicting risk of secondary progression in multiple sclerosis: A nomogramAli Manouchehrinia, Feng Zhu, Daniela Piani-Meier, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
BMC Neurology|July 22, 2019
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patientsNick Bansback, Judy A Chiu, Robert Carruthers, et al.
Medicine|June 25, 2013
IgG4-related disease and hypertrophic pachymeningitisZachary S Wallace, Mollie N Carruthers, Arezou Khosroshahi, et al.
NPJ Digital Medicine|November 5, 2022
Representational ethical model calibrationRobert Carruthers, Isabel Straw, James K Ruffle, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 5, 2021
Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosisNick Bansback, Judy A Chiu, Rebecca Metcalfe, et al.
BMJ Open|June 4, 2017
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopeniaKaarina Kowalec, Elaine Kingwell, Robert Carruthers, et al.
Retina (Philadelphia, Pa.)|March 24, 2021
INVESTIGATING MICROANGIOPATHY USING SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH SUSAC SYNDROMEMagdalena A Wirth, Haaris M Khan, Jillian Chan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Effect of different doses of gadolinium contrast agent on clinical outcomes in MSNathalie Ackermans, Carolyn Taylor, Roger Tam, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 9, 2021
Diffusely abnormal white matter in multiple sclerosisJames Cairns, Irene M Vavasour, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2017
Age Related Multiple Sclerosis Severity Score: Disability ranked by ageAli Manouchehrinia, Helga Westerlind, Elaine Kingwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Predicting risk of secondary progression in multiple sclerosis: A nomogramAli Manouchehrinia, Feng Zhu, Daniela Piani-Meier, et al.
Pageof 6